Effect of calcium and vitamin D supplementation on bone mineral density in children with inflammatory bowel disease

Eric I. Benchimol, Leanne M. Ward, John Christopher G. Gallagher, Frank Rauch, Nick Barrowman, Jaime Warren, Susan Beedle, David R. Mack

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

OBJECTIVES: The purpose of this study was to evaluate the effect of calcium and vitamin D2 supplementation on bone mineral density (BMD) in children with inflammatory bowel disease (IBD). PATIENTS AND METHODS: This was an open-label, prospective study conducted over a 12-month period. Seventy-two patients were divided into 2 groups based on lumbar spine areal BMD (L2-4 aBMD). Patients with an L2-4 aBMD z score of -1 or higher were assigned to the control group (n = 33; mean age, 11.0 ± 3.5 years; 20 boys). Patients with an L2-4 aBMD of less than -1 (n = 39; mean age 11.8 ± 2.5 years; 25 boys) were allocated to the intervention group and received 1000 mg of supplemental elemental calcium daily for 12 months (n = 19) or supplemental calcium for 12 months and 50,000 IU of vitamin D2 monthly for 6 months (n = 20). RESULTS: The 2 groups differed in L2-4 aBMD z scores (intervention, -1.9 ± 0.6; control, -0.2 ± 0.6; P <0.001) and volumetric L2-4 BMD (vBMD; intervention, 0.29 ± 0.04; control, 0.33 ± 0.06; P <0.001). After 1 year of therapy, the control and intervention groups had similar changes in height z scores, L2-4 aBMD, L2-4 vBMD (z score change, L2-4 aBMD: control 0.2 ± 0.6 [n = 21], intervention 0.4 ± 0.6; P = 0.4 [n = 26]; z score change, L2-4 vBMD: control 0.1 ± 0.4, intervention 0.2 ± 0.6; P = 0.74). The changes in these parameters were similar between patients who had received calcium only or calcium plus vitamin D. CONCLUSIONS: These results suggest that, in children with IBD, supplementation of calcium and vitamin D does not accelerate accrual in L2-4 BMD.

Original languageEnglish
Pages (from-to)538-545
Number of pages8
JournalJournal of Pediatric Gastroenterology and Nutrition
Volume45
Issue number5
DOIs
StatePublished - Nov 2007

Fingerprint

inflammatory bowel disease
bone density
vitamin D
Inflammatory Bowel Diseases
Vitamin D
Bone Density
Calcium
calcium
ergocalciferol
Ergocalciferols
lumbar spine
Control Groups
prospective studies
Spine
Prospective Studies
therapeutics

All Science Journal Classification (ASJC) codes

  • Gastroenterology
  • Histology
  • Medicine (miscellaneous)
  • Food Science
  • Pediatrics, Perinatology, and Child Health

Cite this

Effect of calcium and vitamin D supplementation on bone mineral density in children with inflammatory bowel disease. / Benchimol, Eric I.; Ward, Leanne M.; Gallagher, John Christopher G.; Rauch, Frank; Barrowman, Nick; Warren, Jaime; Beedle, Susan; Mack, David R.

In: Journal of Pediatric Gastroenterology and Nutrition, Vol. 45, No. 5, 11.2007, p. 538-545.

Research output: Contribution to journalArticle

Benchimol, Eric I. ; Ward, Leanne M. ; Gallagher, John Christopher G. ; Rauch, Frank ; Barrowman, Nick ; Warren, Jaime ; Beedle, Susan ; Mack, David R. / Effect of calcium and vitamin D supplementation on bone mineral density in children with inflammatory bowel disease. In: Journal of Pediatric Gastroenterology and Nutrition. 2007 ; Vol. 45, No. 5. pp. 538-545.
@article{58bbddbdf46e4b36bb3868d878b0e11a,
title = "Effect of calcium and vitamin D supplementation on bone mineral density in children with inflammatory bowel disease",
abstract = "OBJECTIVES: The purpose of this study was to evaluate the effect of calcium and vitamin D2 supplementation on bone mineral density (BMD) in children with inflammatory bowel disease (IBD). PATIENTS AND METHODS: This was an open-label, prospective study conducted over a 12-month period. Seventy-two patients were divided into 2 groups based on lumbar spine areal BMD (L2-4 aBMD). Patients with an L2-4 aBMD z score of -1 or higher were assigned to the control group (n = 33; mean age, 11.0 ± 3.5 years; 20 boys). Patients with an L2-4 aBMD of less than -1 (n = 39; mean age 11.8 ± 2.5 years; 25 boys) were allocated to the intervention group and received 1000 mg of supplemental elemental calcium daily for 12 months (n = 19) or supplemental calcium for 12 months and 50,000 IU of vitamin D2 monthly for 6 months (n = 20). RESULTS: The 2 groups differed in L2-4 aBMD z scores (intervention, -1.9 ± 0.6; control, -0.2 ± 0.6; P <0.001) and volumetric L2-4 BMD (vBMD; intervention, 0.29 ± 0.04; control, 0.33 ± 0.06; P <0.001). After 1 year of therapy, the control and intervention groups had similar changes in height z scores, L2-4 aBMD, L2-4 vBMD (z score change, L2-4 aBMD: control 0.2 ± 0.6 [n = 21], intervention 0.4 ± 0.6; P = 0.4 [n = 26]; z score change, L2-4 vBMD: control 0.1 ± 0.4, intervention 0.2 ± 0.6; P = 0.74). The changes in these parameters were similar between patients who had received calcium only or calcium plus vitamin D. CONCLUSIONS: These results suggest that, in children with IBD, supplementation of calcium and vitamin D does not accelerate accrual in L2-4 BMD.",
author = "Benchimol, {Eric I.} and Ward, {Leanne M.} and Gallagher, {John Christopher G.} and Frank Rauch and Nick Barrowman and Jaime Warren and Susan Beedle and Mack, {David R.}",
year = "2007",
month = "11",
doi = "10.1097/MPG.0b013e3180dca0cc",
language = "English",
volume = "45",
pages = "538--545",
journal = "Journal of Pediatric Gastroenterology and Nutrition",
issn = "0277-2116",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Effect of calcium and vitamin D supplementation on bone mineral density in children with inflammatory bowel disease

AU - Benchimol, Eric I.

AU - Ward, Leanne M.

AU - Gallagher, John Christopher G.

AU - Rauch, Frank

AU - Barrowman, Nick

AU - Warren, Jaime

AU - Beedle, Susan

AU - Mack, David R.

PY - 2007/11

Y1 - 2007/11

N2 - OBJECTIVES: The purpose of this study was to evaluate the effect of calcium and vitamin D2 supplementation on bone mineral density (BMD) in children with inflammatory bowel disease (IBD). PATIENTS AND METHODS: This was an open-label, prospective study conducted over a 12-month period. Seventy-two patients were divided into 2 groups based on lumbar spine areal BMD (L2-4 aBMD). Patients with an L2-4 aBMD z score of -1 or higher were assigned to the control group (n = 33; mean age, 11.0 ± 3.5 years; 20 boys). Patients with an L2-4 aBMD of less than -1 (n = 39; mean age 11.8 ± 2.5 years; 25 boys) were allocated to the intervention group and received 1000 mg of supplemental elemental calcium daily for 12 months (n = 19) or supplemental calcium for 12 months and 50,000 IU of vitamin D2 monthly for 6 months (n = 20). RESULTS: The 2 groups differed in L2-4 aBMD z scores (intervention, -1.9 ± 0.6; control, -0.2 ± 0.6; P <0.001) and volumetric L2-4 BMD (vBMD; intervention, 0.29 ± 0.04; control, 0.33 ± 0.06; P <0.001). After 1 year of therapy, the control and intervention groups had similar changes in height z scores, L2-4 aBMD, L2-4 vBMD (z score change, L2-4 aBMD: control 0.2 ± 0.6 [n = 21], intervention 0.4 ± 0.6; P = 0.4 [n = 26]; z score change, L2-4 vBMD: control 0.1 ± 0.4, intervention 0.2 ± 0.6; P = 0.74). The changes in these parameters were similar between patients who had received calcium only or calcium plus vitamin D. CONCLUSIONS: These results suggest that, in children with IBD, supplementation of calcium and vitamin D does not accelerate accrual in L2-4 BMD.

AB - OBJECTIVES: The purpose of this study was to evaluate the effect of calcium and vitamin D2 supplementation on bone mineral density (BMD) in children with inflammatory bowel disease (IBD). PATIENTS AND METHODS: This was an open-label, prospective study conducted over a 12-month period. Seventy-two patients were divided into 2 groups based on lumbar spine areal BMD (L2-4 aBMD). Patients with an L2-4 aBMD z score of -1 or higher were assigned to the control group (n = 33; mean age, 11.0 ± 3.5 years; 20 boys). Patients with an L2-4 aBMD of less than -1 (n = 39; mean age 11.8 ± 2.5 years; 25 boys) were allocated to the intervention group and received 1000 mg of supplemental elemental calcium daily for 12 months (n = 19) or supplemental calcium for 12 months and 50,000 IU of vitamin D2 monthly for 6 months (n = 20). RESULTS: The 2 groups differed in L2-4 aBMD z scores (intervention, -1.9 ± 0.6; control, -0.2 ± 0.6; P <0.001) and volumetric L2-4 BMD (vBMD; intervention, 0.29 ± 0.04; control, 0.33 ± 0.06; P <0.001). After 1 year of therapy, the control and intervention groups had similar changes in height z scores, L2-4 aBMD, L2-4 vBMD (z score change, L2-4 aBMD: control 0.2 ± 0.6 [n = 21], intervention 0.4 ± 0.6; P = 0.4 [n = 26]; z score change, L2-4 vBMD: control 0.1 ± 0.4, intervention 0.2 ± 0.6; P = 0.74). The changes in these parameters were similar between patients who had received calcium only or calcium plus vitamin D. CONCLUSIONS: These results suggest that, in children with IBD, supplementation of calcium and vitamin D does not accelerate accrual in L2-4 BMD.

UR - http://www.scopus.com/inward/record.url?scp=37349070332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37349070332&partnerID=8YFLogxK

U2 - 10.1097/MPG.0b013e3180dca0cc

DO - 10.1097/MPG.0b013e3180dca0cc

M3 - Article

VL - 45

SP - 538

EP - 545

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

SN - 0277-2116

IS - 5

ER -